Page last updated: 2024-09-04

cyc 202 and Recrudescence

cyc 202 has been researched along with Recrudescence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, CE; Edwards, J; Fyffe, G; Heng, SJ; Horgan, PG; Leung, HY; McCall, P; Seywright, M; Tannahill, C; Underwood, MA; Willder, JM	1

Other Studies

1 other study(ies) available for cyc 202 and Recrudescence

Article	Year
Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients. British journal of cancer, 2013, Jan-15, Volume: 108, Issue:1 Topics: Aged; Biomarkers, Tumor; CDC2 Protein Kinase; Disease-Free Survival; Humans; Male; MAP Kinase Signaling System; Phosphorylation; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Purines; Receptors, Androgen; Recurrence; Roscovitine; Serine	2013

Article

Year

Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients.

British journal of cancer, 2013, Jan-15, Volume: 108, Issue:1

Topics: Aged; Biomarkers, Tumor; CDC2 Protein Kinase; Disease-Free Survival; Humans; Male; MAP Kinase Signaling System; Phosphorylation; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Purines; Receptors, Androgen; Recurrence; Roscovitine; Serine

2013